You are here

T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?

TitleT cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
Publication TypeJournal Article
Year of Publication2003
AuthorsPosavad, CM, Wald, A, Hosken, N, Huang, ML, Koelle, DM, Ashley, RL, Corey, L
JournalJ Immunol
Volume170
Issue8
Pagination4380-8
Date Published2003 Apr 15
ISSN0022-1767
KeywordsAdult, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Clone Cells, Epitopes, T-Lymphocyte, Female, Herpes Genitalis, Herpes Labialis, Herpes Simplex, Herpes Simplex Virus Vaccines, Herpesvirus 1, Human, Herpesvirus 2, Human, Humans, Immunity, Active, Immunity, Cellular, Lymphocyte Activation, Lymphocyte Count, Male, T-Lymphocyte Subsets, T-Lymphocytes, Cytotoxic
Abstract

During the course of investigating T cell responses to HSV among volunteers entering trials of investigational genital herpes vaccines, 6 of the 24 immunocompetent subjects with no prior history of oral/labial or genital herpes possessed HSV-specific T cell immunity but, by multiple determinants of even the most sensitive serological assays, remained seronegative to HSV-1 and -2. Of these six immune seronegative (IS; HSV-seronegative with HSV-specific T cell responses) subjects, two had transient HSV-specific T cell responses, while four had CD4(+) and CD8(+) T cell responses directed at HSV that persisted for up to 4 years. CD4(+) T cell clones were isolated that recognized and had high binding affinities to epitopes in HSV-2 tegument proteins. All six IS subjects had potential sexual exposure to an HSV-2-infected sexual partner. Oral and genital mucosal secretions were sampled and tested for the presence of infectious HSV and HSV DNA. No evidence of HSV was detected in >1500 samples obtained from these IS subjects. The identification of persistent T cell responses to HSV in seronegative subjects is a novel finding in the herpesvirus field and suggests either undetected infection or acquired immunity in the absence of infection. Understanding the basis of these acquired immune responses may be critical in developing effective vaccines for genital herpes.

Alternate JournalJ. Immunol.
PubMed ID12682275